Tagged drug-discovery-and-development
Press Release
Characterization of Oral Gut-Selective vs. Systemic JAK Inhibitors in the Mouse Oxazalone Colitis Model, New Webinar Hosted by Xtalks
Autoimmune diseases such as ulcerative colitis require chronic treatment that often causes systemic immunosuppression, increasing long-term cancer and infection risk. Reducing systemic side effects with localized treatment would greatly benefit patients. Read More
Press Release
Expediting Dry Powder Inhaler Formulation Development Through Modelling and Advanced Characterization, New Webinar Hosted by Xtalks
Dry powder inhalers are gaining increasing momentum for drug delivery to the lungs. One of the most used and flexible delivery technologies are capsule-based dry powder inhalers Read More
Press Release
Drug Development - the 6 Most Critical Reasons Why Drugs Are Delayed When Planning and Conducting CTA/IND Enabling Studies, New Webinar Hosted by Xtalks
Bringing a drug from discovery to market is an expensive and time-consuming business. Every drug that fails comes with a cost which could be both reputational and financial. Keeping your development program on track is therefore critical to success. Read More
Press Release
Better Target Validation for Drug Discovery With CRISPR/Cas9, New Webinar Hosted by Xtalks
Better target validation is a key driver of better productivity in drug discovery. The RNA-guided nucleases, exemplified by Cas9, represent a powerful new approach to understanding gene function and, in principle, to reveal the next generation of therapeutic targets. But how well does this technology work in practice? Read More
Press Release
